Report cover image

Japan Auto-Injectors for Glp-1 Receptor Agonists Market Outlook 2038

Published Jul 04, 2025
Length 90 Pages
SKU # RENE20451223

Description

Japan auto-injectors for GLP-1 receptor agonists market is valued at USD 137.7 million in 2025 and is expected to reach USD 292.9 million by 2038, rising at a CAGR of 6.1% over the forecast period from 2026 to 2038. In 2026, the market size is projected to reach USD 143.8 million. The market for auto-injectors targeting GLP-1 receptor agonists in Japan is gaining momentum due to the rise in type 2 diabetes and obesity-related health complications. As these medications are increasingly prescribed for glycemic control and weight loss, demand for convenient, at-home delivery methods is growing. Auto-injectors offer precise dosing, reduced needle anxiety, and enhanced patient compliance—making them a preferred solution among both patients and healthcare providers. Furthermore, Japan’s aging population and shifting pharmaceutical delivery models are encouraging broader adoption of self-injection therapies. Innovation in device design, including smart injectors and wearable formats, is expected to further accelerate market uptake.

Table of Contents

90 Pages
Japan Auto-Injectors for Glp-1 Receptor Agonists Market
Market Overview
Assumptions and Abbreviations
Research Methodology & Approach
Primary Research
Secondary Research
SPSS Methodology
Data Triangulation
Executive Summary
Value Chain Analysis
Auto-Injector Value Chain: From Materials to Market
Japan’s Leading Auto-Injector Suppliers: Global Export Insights
Comparative Positioning
Competitive Landscape: Key Players
AstraZeneca
BECTON, DICKINSON AND COMPANY
ELI LILLY AND COMPANY
Nemera
Novo Nordisk A/S
Owen Mumford Pharmaceutical Services
SHL Medical AG
Sanofi
Ypsomed Holding AG
About Research Nester
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.